-
Abbott Labs Sued On Claim Humira Caused Lasting Nerve Damage -Bloomberg (ABT)
Tuesday, April 26, 2011 - 11:10am | 22Abbott Laboratories (NYSE: ABT) sued on claim Humira caused lasting nerve damage reports Bloomberg.
-
Government Trying To Get Rid Of CEO Called A "Game-Changer" (FRX)
Tuesday, April 26, 2011 - 10:32am | 347The Obama administration has made no secret that it views company CEO's as a foe, especially with the latest effort to try to get rid of Howard Solomon of Forest Laboratories Inc. (NYSE: FRX). In an article in the Wall Street Journal, The Department of Health and Human Services this month...
-
CEOWORLD Stocks Picks to Watch on 4/26/11 – NFLX, BIDU, ORCL, YRCW, KOG, SSN, AMZN, PZG, AIG, AMD, GS, POT…
Tuesday, April 26, 2011 - 10:05am | 1769Netflix, Inc. (NFLX)- Netflix, Inc. is a subscription service streaming movies and television episodes over the Internet and sending digital versatile discs (DVDs) by mail to more than 12 million subscribers. The Company's subscribers can watch unlimited movies and television episodes streamed to...
-
Jefferies Comments On Bristol-Myers Squibb
Tuesday, April 26, 2011 - 9:41am | 200Bristol-Myers Squibb's (NYSE: BMY) Q1'11 earnings are expected to decline YoY due to higher operational costs combined with the impact of healthcare reform and Avalide supply issues. Whilst the strong new product launches and catalyst set command a premium valuation versus its peers, the shares are...
-
LifeTech Capital Positive On Marina Biotech (MRNA)
Tuesday, April 26, 2011 - 9:20am | 184LifeTech Capital is positive on Marina Biotech (NASDAQ: MRNA), and rates shares at "Strong Speculative Buy." It has a $2.50 price target on shares. In a note to clients, LifeTech writes, "Marina Biotech announced the publication of data for their DiLA2-based delivery technology for systemic...
-
Morgan Stanley Resumes Coverage On Forest Laboratories At Equal-Weight
Tuesday, April 26, 2011 - 9:08am | 163Morgna Stanley is resuming coverage on Forest Laboratories (NYSE: FRX) with an Equal-weight rating and DCF-based $35 PT. Acquisition of Clinical Data brought a new antidepressant (Viibryd) that should begin shipping in 2Q. Morgan Stanley sees risk-reward skewed slightly to the upside. Positive...
-
Lilly and Medtronic Announce Drug-Device Collaboration for Parkinson's Disease
Tuesday, April 26, 2011 - 9:01am | 99Eli Lilly and Company (NYSE: LLY) and Medtronic, Inc. (NYSE: MDT) today announced they have entered into a collaboration to research and develop a new approach to treating Parkinson's disease that involves delivering a potential new medicine to the brain using an implantable drug delivery system...
-
CEOWORLD Top 15 Stocks Picks Below $10- RMTR, APP, ACAD, HRZ, AIB, HNSN, QPSA, JRJC, TASR, RPRX, ONTY, LOOK, CT, SHZ, ESLR
Tuesday, April 26, 2011 - 8:30am | 18381) Ramtron International (RMTR)- Ramtron International Corporation (Ramtron) is a fabless semiconductor company that designs, develops and markets specialized semiconductor memory, microcontroller and integrated semiconductor solutions. The Company developed the integration of ferroelectric...
-
Piper Jaffray Reiterates Overweight on XenoPort (XNPT)
Tuesday, April 26, 2011 - 7:34am | 169Piper Jaffray is out with its report today on XenoPort (NASDAQ: XNPT), reiterating Overweight. In a note to clients, Piper Jaffray writes, "Yesterday, Xenoport announced that a Phase III study for XP19986, in multiple sclerosis patients with spasticity will be run under a Special Protocol...
-
CEOWORLD Top 10 Tech Stocks Winning 52-Week Highs- ABB, IBM, ORCL, NVO, BTI, SAP, ERIC, VMW, ACN and MA
Tuesday, April 26, 2011 - 5:29am | 12021) ABB Ltd. (NYSE:ABB)- Down 0.04% to $25.33. Shares of ABB Limited booked a new 52 week high today by trading above $25.39, traders are definitely monitoring ABB's price action to see if this move attracts further buying into the stock. ABB Limited provides power and automation technologies. The...
-
Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, to Take Medical Leave (ACUR)
Monday, April 25, 2011 - 4:11pm | 79Acura Pharmaceuticals (Nasdaq: ACUR) announced that President and Chief Executive Officer Andy Reddick has begun a leave of absence for health reasons for an as-yet undetermined period. Mr. Reddick will continue to serve as a member of the Company's Board of Directors. During Mr. Reddick's absence...
-
Options Brief: Watson Pharmaceuticals, Inc. (WPI)
Monday, April 25, 2011 - 11:27am | 88Shares of Watson Pharmaceuticals, Inc. (NYSE: WPI) are higher on the session by 0.36%, trading at $58.36. Overall put volume is now running at 9.36x the daily average, with 0% of all puts traded being purchases on the offer. 1,151 contracts have traded on the session so far. Watson...
-
Hot Stocks to Buy on 4/25/11 and April 26, 2011- TZOO, NWD, JKS, SHZ, SINA, BIIB, CSNHD…
Monday, April 25, 2011 - 10:57am | 1814Travelzoo Inc. (TZOO) - Travelzoo hit a new 52-week high Monday as it is currently trading at $97.65, above its previous 52-week high of $95.45 with 112,564 shares traded as of 9:32 a.m. ET. Average volume has been 670,000 shares over the past 30 days. New Dragon Asia Corp. (AMEX:NWD) - New...
-
Ardea Biosciences to Present Additional Data From Completed Phase 2b Combination Study of Lesinurad and Allopurinol
Monday, April 25, 2011 - 9:04am | 118Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced that additional data from its completed Phase 2b study evaluating lesinurad in combination with allopurinol in gout patients not adequately responding to allopurinol alone will be presented at the Annual European Congress of Rheumatology hosted...
-
Rwanda, Merck and QIAGEN Launch Africa's First Comprehensive Cervical Cancer Prevention Program Incorporating Both HPV Vaccination and HPV Testing
Monday, April 25, 2011 - 8:35am | 117The Government of Rwanda, together with QIAGEN N.V. (NASDAQ: QGEN) and Merck (NYSE: MRK) today announced the launch, in Kigali, Rwanda, of a comprehensive national cervical cancer prevention program that includes vaccination with GARDASIL for appropriate girls 12 to 15 years of age and modern...